The Use of Opioids and Pain Medications in the Management of Postoperative Pain in Total Knee Arthroplasty Patients: A Retrospective Study

dc.contributor.authorAlmustafa, Ammar
dc.contributor.authorDer-Boghossian, Asdghig H.
dc.contributor.authorSheikh Taha, Abdel Majid
dc.contributor.departmentSurgery
dc.contributor.departmentDivision Of Orthopedic Surgery
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T12:13:54Z
dc.date.available2025-01-24T12:13:54Z
dc.date.issued2022
dc.description.abstractPurpose. The opioid crisis amplified the concern for the appropriate use of opioids. Our study aims to investigate the pain levels and amount of opiates needed during the first three days following total knee arthroplasty (TKA), whereby Drug Enforcement Administration (DEA) Schedule II oral opiates are not available. Methods. A year-long retrospective review of adult patients who underwent TKA was conducted. The postoperative pain scores and mean morphine equivalents (MME) were measured. These outcomes were assessed according to demographics, anesthesia, and analgesia used. Results. For our 78 patients, there was no statistical difference for stratification by baseline characteristics except in spinal anesthesia, which decreased pain on the first day. Conversely, MME increased to its significantly highest of 14.22 ± 29.58 mg on day 3. The effect was noted for patient-controlled analgesia where patients with intravenous analgesia received less opioid than those on epidural analgesia on postoperative day one. Conclusions. Using a similar regimen of analgesia, postoperative pain following TKA would be controlled by a relatively low amount of opioids by the third postoperative day. Spinal anesthesia and patient-controlled epidural analgesia were linked to better pain control and less opioid needed. © 2022 Ammar Almustafa et al.
dc.identifier.doihttps://doi.org/10.1155/2022/7445144
dc.identifier.eid2-s2.0-85128571587
dc.identifier.pmid35391854
dc.identifier.urihttp://hdl.handle.net/10938/33114
dc.language.isoen
dc.publisherHindawi Limited
dc.relation.ispartofPain Research and Management
dc.sourceScopus
dc.subjectAdult
dc.subjectAnalgesia, patient-controlled
dc.subjectAnalgesics, opioid
dc.subjectArthroplasty, replacement, knee
dc.subjectHumans
dc.subjectMorphine
dc.subjectPain, postoperative
dc.subjectRetrospective studies
dc.subjectBupivacaine
dc.subjectFentanyl
dc.subjectLocal anesthetic agent
dc.subjectOpiate
dc.subjectParacetamol
dc.subjectNarcotic analgesic agent
dc.subjectAged
dc.subjectAnalgesia
dc.subjectArticle
dc.subjectDemographics
dc.subjectDrug use
dc.subjectEpidural analgesia
dc.subjectFemale
dc.subjectGovernment
dc.subjectHuman
dc.subjectKnee osteoarthritis
dc.subjectMajor clinical study
dc.subjectMale
dc.subjectObservational study
dc.subjectPain assessment
dc.subjectPain intensity
dc.subjectPatient controlled analgesia
dc.subjectPostoperative pain
dc.subjectPostoperative period
dc.subjectRetrospective study
dc.subjectSpinal anesthesia
dc.subjectTotal knee arthroplasty
dc.subjectAdverse event
dc.subjectKnee replacement
dc.titleThe Use of Opioids and Pain Medications in the Management of Postoperative Pain in Total Knee Arthroplasty Patients: A Retrospective Study
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2022-2145.pdf
Size:
1.12 MB
Format:
Adobe Portable Document Format

Collections